The CMML‐like disease, for instance, included patients with either biallelic TET2 mutations, TET2 and SRSF2 co‐mutation, or RUNX1 and SRSF2 co‐mutation; survival curves were similar between this group and WHO‐classified CMML patients. This evidence concerns the gene RUNX1 and chronic myelomonocytic leukemia.